8th International Symposium on Age-related Macular Degeneration: Understanding pathogenetic mechanism – towards clinical translation
08. - 09.09.2023, Baden-Baden
Neovascular AMD and Imaging
Meeting Abstract
(23amd18)
[Full Text]
The BIOMAC-Study: modulation of CNV activity in nAMD and anti-VEGF treatment need through systemic factors
Zeitz O, Flesch L, Knecht V, Frentzel DP, Rau S, Rübsam A, Künzel SE, Wolf S, Dreher F, Schuette M, Lange B, Yaspo ML, Lehrach H, Joussen AM[Full Text]
Meeting Abstract
(23amd19)
[Full Text]
Long-term choroidal thickness changes after anti-VEGF treatment for neovascular AMD depending on the type of macular neovascularisation (5-year follow-up)
Abdin AD, Hanifa O, Weinstein I, Munteanu C, Seitz B[Full Text]
Meeting Abstract
(23amd20)
[Full Text]
Short-term results of intravitreal faricimab for refractory nMD
Aljundi W, Munteanu C, Seitz B, Abdin AD[Full Text]
Meeting Abstract
(23amd21)
[Full Text]
Progression of type 1 macular neovascularization into aneurysmal polypoidal choroidal vasculopathy within the pachychoroid spectrum
Siedlecki J, Klaas JE, Keidel LF, Asani B, Luft N, Priglinger SG, Schworm B[Full Text]
Meeting Abstract
(23amd22)
[Full Text]
Preliminary clinical and progression analysis of a prospective cohort study of unilateral nAMD
Cinque F, ten Brink S, Shahabi M, de Breuk A, Heesterbeek T, Klaver C, Hoyng C, Lechanteur Y[Full Text]